Market Overview:

• The global infection control market size reached USD 28.1 Billion in 2024.
• The market is expected to reach USD 49.7 Billion by 2033, exhibiting a growth rate (CAGR) of 6.22% during 2025-2033.
• North America leads the market, accounting for the largest infection control market share.
• A surge in infection prevention awareness, fueled by targeted education and training, is fundamentally reshaping healthcare practices and driving market expansion.
• Empowering healthcare professionals and patients with knowledge about infection transmission is creating a proactive demand for cutting-edge infection control solutions.
• The shift towards a culture of safety, driven by widespread awareness campaigns, is emphasizing the critical role of hygiene and advanced infection control measures.
• Investing in educational programs is proving to be a powerful catalyst for market growth, as informed stakeholders actively seek and implement effective infection prevention strategies.
• By highlighting the tangible benefits of infection control, awareness initiatives are not just boosting market demand but also significantly improving patient outcomes and reducing healthcare burdens.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://www.imarcgroup.com/infection-control-market/requestsample

Our report includes:

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Factors Affecting the Growth of the Infection Control Industry:

• Increased Prevalence of Hospital-Acquired Infections (HAIs):

The increasing prevalence of hospital acquired infections (HAIs) around the world has led to changes in infection control requirements. Hospital Acquired Infections are risky for health because they can lead to lengthened hospitalization, excess health care costs, and higher mortality rates. The realization of risk and harm resulting from hospital-acquired infections, as well as the need to minimize infection (through sterilization equipment, disinfectants, and protective barriers), have resulted in increased demand for infection control equipment. Healthcare facilities are also adopting infection control practices to prevent the spread of pathogens that are infectious and harmful to patients, which drives market growth. Ultimately, the variety of infection control practices will ensure patient safety and quality in healthcare delivery.

• Technological Advancements in Infection Control Products:

Innovations and advances in technology of infection control products are important factors promoting growth in the marketplace. More effective, user-friendly and environmentally safe products have made infection control practices more effective. Increased performance delivered by technologies such as low-temperature sterilizers and UV disinfection systems have offered better performance than regular sterilization and discontinued use of chemical sterilants. Moreover, the introduction of these new innovations is not only met with a higher standard of infection prevention, but it also aids sustainability goals through less chemical and energy utilization. The progression of infection control technologies warrants market growth, anticipating and satisfying the evolving marketplace for infection control products in healthcare.

• Stringent Regulatory Guidelines and Recommendations:

Internationally, regulatory agencies have developed stringent guidelines and recommendations to prevent and manage infections in health care settings. These regulations require infection control practices to be followed in many areas of health care delivery including surgical practices and use of medical equipment. Following the guidelines involves considerable spending on infection control products and services, which is helping to create opportunities for market growth for infection control products and services. The focus on regulatory guidelines for infection prevention and control illustrates the seriousness of the importance of infection control practices in protecting patient health and increasing the quality of care.

Leading Companies Operating in the Global Infection Control Industry:

• 3M Company
• Advanced Sterlization Products Services Inc. (Fortive Corporation)
• Belimed AG (Metall Zug)
• Cantel Medical Corp.
• Getinge AB
• Matachana
• Metrex Research LLC (Envista Holdings and Sybron Dental Specialities Inc.)
• MMM Münchener Medizin Mechanik GmbH
• Pal International
• Sterigenics U.S. LLC (Sotera Health Holdings LLC)
• Steris Corporation
• TSO3 Inc. (Stryker Corporation)

Infection Control Market Report Segmentation:

By Type:

• Equipment
  • Disinfectors
    • Washers
    • Flushers
    • Ultrasonic Cleaners
  • Sterilization Equipment
    • Heat Sterilization
    • Low Temperature Sterilization
    • Radiation Sterilization
    • Filtration-Based Sterilization
  • Others
• Services
  • Contract Sterilization
    • ETO Sterilization
    • Gamma Sterilization
    • E-Beam Sterilization
    • Steam Sterilization
  • Infectious Waste Disposal
• Consumables
  • Disinfectants
  • Sterilization Consumables
  • Personal Protective Equipment
  • Others

Consumables hold the biggest market share as they are designed for ease of use and compatibility with existing healthcare protocols, thereby enhancing compliance with safety and hygiene standards.

By End User:

• Hospitals and Clinics
• Medical Device Companies
• Clinical Laboratories
• Pharmaceutical Companies
• Others

Hospitals and clinics represent the largest segment owing to the increasing number of patients seeking effective healthcare solutions.

Regional Insights:

• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

North America’s dominance in the infection control market is attributed to the rising emergence of novel pathogens.

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: [email protected]

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145